Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

被引：0
|
作者：
Jun Gong
Shant Thomassian
Sungjin Kim
Gillian Gresham
Natalie Moshayedi
Jason Y. Ye
Julianne C. Yang
Jonathan P. Jacobs
Simon Lo
Nick Nissen
Srinivas Gaddam
Mourad Tighiouart
Arsen Osipov
Andrew Hendifar
机构：
[1] Samuel Oschin Comprehensive Cancer Institute,Department of Medicine
[2] Cedars-Sinai Medical Center,The Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine
[3] University of California,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma (vol 12, 15013, 2022)
    Gong, Jun
    Thomassian, Shant
    Kim, Sungjin
    Gresham, Gillian
    Moshayedi, Natalie
    Ye, Jason Y.
    Yang, Julianne C.
    Jacobs, Jonathan P.
    Lo, Simon
    Nissen, Nick
    Gaddam, Srinivas
    Tighiouart, Mourad
    Osipov, Arsen
    Hendifar, Andrew
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
    Jun Gong
    Shant Thomassian
    Sungjin Kim
    Gillian Gresham
    Natalie Moshayedi
    Jason Y. Ye
    Julianne C. Yang
    Jonathan P. Jacobs
    Simon Lo
    Nick Nissen
    Srinivas Gaddam
    Mourad Tighiouart
    Arsen Osipov
    Andrew Hendifar
    Scientific Reports, 12
  • [3] Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
    Gong, Jun
    Thomassian, Shant
    Kim, Sungjin
    Gresham, Gillian
    Moshayedi, Natalie
    Ye, Jason Y.
    Yang, Julianne C.
    Jacobs, Jonathan P.
    Lo, Simon
    Nissen, Nick
    Gaddam, Srinivas
    Tighiouart, Mourad
    Osipov, Arsen
    Hendifar, Andrew
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX)
    Atkins, Katelyn Mae
    Gong, Jun
    Tighiouart, Mourad
    Klempner, Samuel J.
    Tuli, Richard
    Placencio-Hickok, Veronica
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [5] Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
    Park, Se Jun
    Kim, Hyunho
    Shin, Kabsoo
    Hong, Tae Ho
    Suh, Ja Hee
    Lee, Myung Ah
    BMC CANCER, 2021, 21 (01)
  • [6] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).
    Hendifar, Andrew Eugene
    Kim, Sungjin
    Tighiouart, Mourad
    Hautamaki, Emily
    Kim, Haesoo
    Ng, Camille
    Liu, Jar-Yee
    Scher, Kevin S.
    Klempner, Samuel J.
    Placencio-Hickok, Veronica
    Gresham, Gillian
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
    Se Jun Park
    Hyunho Kim
    Kabsoo Shin
    Tae Ho Hong
    Ja Hee Suh
    Myung Ah Lee
    BMC Cancer, 21
  • [8] A phase I trial of trifluridine/tipiracil in combination with nanoliposomal irinotecan in advanced GI cancers
    Alese, O.
    Shaib, W.
    Akce, M.
    Diab, M.
    Issa-Boube, M.
    Ekundayo, F.
    Wu, C.
    El-Rayes, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S200 - S200
  • [9] Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
    Bockorny, Bruno
    Macarulla, Teresa
    Semenisty, Valerya
    Borazanci, Erkut
    Feliu, Jaime
    Ponz-Sarvise, Mariano
    Abad, David Gutierrez
    Oberstein, Paul
    Alistar, Angela
    Munoz, Andres
    Geva, Ravit
    Guillen-Ponce, Carmen
    Fernandez, Mercedes Salgado
    Peled, Amnon
    Chaney, Marya
    Gliko-Kabir, Irit
    Shemesh-Darvish, Liron
    Ickowicz, Debby
    Sorani, Ella
    Kadosh, Shaul
    Vainstein-Haras, Abi
    Hidalgo, Manuel
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 5020 - 5027
  • [10] A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium
    Verbruggen, Lise
    Verheggen, Lisa
    Vanhoutte, Greetje
    Loly, Catherine
    Lybaert, Willem
    Borbath, Ivan
    Vergauwe, Philippe
    Hendrickx, Koen
    Debeuckelaere, Celine
    de Haar-Holleman, Amy
    Van Laethem, Jean-Luc
    Peeters, Marc
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
12345